nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Pain of skin—Bleomycin—lymphatic system cancer	0.126	0.126	CcSEcCtD
Adapalene—Optic neuritis—Fludarabine—lymphatic system cancer	0.0661	0.0661	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Fludarabine—lymphatic system cancer	0.0596	0.0596	CcSEcCtD
Adapalene—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0476	0.0476	CcSEcCtD
Adapalene—Sunburn—Methotrexate—lymphatic system cancer	0.0399	0.0399	CcSEcCtD
Adapalene—Burning sensation—Carmustine—lymphatic system cancer	0.0374	0.0374	CcSEcCtD
Adapalene—Skin exfoliation—Bleomycin—lymphatic system cancer	0.0285	0.0285	CcSEcCtD
Adapalene—Skin exfoliation—Carmustine—lymphatic system cancer	0.0248	0.0248	CcSEcCtD
Adapalene—Eye pain—Carmustine—lymphatic system cancer	0.0209	0.0209	CcSEcCtD
Adapalene—Face oedema—Carmustine—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Adapalene—Burning sensation—Methotrexate—lymphatic system cancer	0.0173	0.0173	CcSEcCtD
Adapalene—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Adapalene—Pruritus—Mechlorethamine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Adapalene—Convulsion—Fludarabine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Adapalene—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Adapalene—Rash—Mechlorethamine—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Adapalene—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Adapalene—Skin discolouration—Methotrexate—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Adapalene—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Adapalene—Urticaria—Teniposide—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Adapalene—Erythema—Bleomycin—lymphatic system cancer	0.013	0.013	CcSEcCtD
Adapalene—Pain—Fludarabine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Adapalene—Hypersensitivity—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Adapalene—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Adapalene—Pruritus—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Adapalene—Erythema—Carmustine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Adapalene—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Adapalene—Erythema—Mitoxantrone—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Adapalene—Rash—Teniposide—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Adapalene—Dermatitis—Teniposide—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Adapalene—Pruritus—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Adapalene—Convulsion—Carmustine—lymphatic system cancer	0.00985	0.00985	CcSEcCtD
Adapalene—Convulsion—Vincristine—lymphatic system cancer	0.00941	0.00941	CcSEcCtD
Adapalene—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00927	0.00927	CcSEcCtD
Adapalene—Convulsion—Mitoxantrone—lymphatic system cancer	0.00916	0.00916	CcSEcCtD
Adapalene—Rash—Fludarabine—lymphatic system cancer	0.00914	0.00914	CcSEcCtD
Adapalene—Dermatitis—Fludarabine—lymphatic system cancer	0.00914	0.00914	CcSEcCtD
Adapalene—Pain—Bleomycin—lymphatic system cancer	0.00909	0.00909	CcSEcCtD
Adapalene—Urticaria—Bleomycin—lymphatic system cancer	0.00845	0.00845	CcSEcCtD
Adapalene—Pain—Carmustine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Adapalene—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Adapalene—Pain—Vincristine—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Adapalene—Pruritus—Bleomycin—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Adapalene—Pain—Mitoxantrone—lymphatic system cancer	0.00738	0.00738	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Adapalene—Urticaria—Mitoxantrone—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Adapalene—Hypersensitivity—Carmustine—lymphatic system cancer	0.00684	0.00684	CcSEcCtD
Adapalene—Rash—Bleomycin—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Adapalene—Dermatitis—Bleomycin—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Adapalene—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Adapalene—Hypersensitivity—Vincristine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Adapalene—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Adapalene—Rash—Carmustine—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Adapalene—Dermatitis—Carmustine—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Adapalene—Rash—Vincristine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Adapalene—Dermatitis—Vincristine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Adapalene—Rash—Mitoxantrone—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Adapalene—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Adapalene—Erythema—Methotrexate—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Adapalene—Convulsion—Methotrexate—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Adapalene—Pain—Methotrexate—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Adapalene—Urticaria—Methotrexate—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Adapalene—Pruritus—Methotrexate—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Adapalene—Rash—Methotrexate—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
